Pete Corish is BroadOak’s VP Business Development in Europe, expanding the recognition of, and access to, BroadOak’s expertise, capabilities and services to European Life Science companies and investors.
With 20 years of experience in core clinical laboratory, Point-of-Care immunoassay, and molecular diagnostics markets, Pete has focused on commercialising R&D and third-party innovative technologies in a number of Life Science and IVD businesses in the UK and US, including Alere, Oxford Gene Technology, Arrow Therapeutics, and Oxonica Healthcare plc. This has included applications for novel nanoparticle biolabels, DNA microarray analysis, genomic technologies for drug development, and new platforms for rapid, in-field diagnostics with digital connectivity. As the former Chief Technology Officer of BBI Solutions, a leading independent provider of diagnostic reagents and services, Pete was responsible for M&A, Commercial Strategic Partnerships and technology Licensing/R&D, building out their product and innovative technology portfolios.
Pete gained his bachelor and doctorate degrees in Molecular Genetics from the Universities of Nottingham and Cambridge (UK) respectively, and is based in Cardiff, the capital of Wales, and only two hours from the principal European Life Science hubs.
Connect with Pete
The scale and dynamics of our industry sector have changed dramatically since BroadOak’s start 15 years ago. Our clients and partners continue to appreciate the consistency of our core focus and approach.
Lars Hanan
Partner
Advisory Services
With unmatched experience and expertise, we help life sciences companies achieve their goals.